What is Doxorubicin injection used for?
Doxorubicin injection is a chemotherapy medication used to treat various types of cancer, including breast cancer, ovarian cancer, lung cancer, and lymphoma [1]. It works by interfering with the growth of cancer cells, which eventually die.
How does Doxorubicin injection compare with other cancer treatments?
While Doxorubicin injection is a commonly used chemotherapy treatment, its effectiveness can vary depending on the type and stage of cancer, as well as individual patient characteristics [2]. It has been compared with other cancer treatments, such as anthracyclines (e.g., epirubicin) and taxanes (e.g., paclitaxel), which have different mechanisms of action and potential side effects.
When does exclusivity expire for Doxorubicin injection?
Doxorubicin injection is a generic medication, and its patent exclusivity has expired. However, there may be ongoing litigation related to this medication, and regulatory approvals for generic versions may be affected [3].
What are the common side effects of Doxorubicin injection?
Common side effects of Doxorubicin injection include hair loss, nausea, vomiting, diarrhea, and fatigue [4]. Patients may also experience cardiac toxicity, alopecia, and mucositis. Side effects can be managed with supportive care measures, such as anti-emetic medication and hydration.
Who makes Doxorubicin injection, and what are the market implications?
Doxorubicin injection is a generic medication, and several manufacturers produce it. The market implications of Doxorubicin injection's generic availability include increased competition and potential price reductions, making it more accessible to patients [5]. However, the production process and quality control measures may vary among manufacturers.
What is the current pricing for Doxorubicin injection?
The current pricing for Doxorubicin injection can vary depending on the manufacturer, batch size, and distribution channel. As a generic medication, Doxorubicin injection is often priced lower than branded cancer treatments. However, prices may fluctuate based on market conditions and regulatory requirements.
Sources:
[1] https://www.drugpatentwatch.com/drug/5t2k7x1h6o/doxorubicin-injection
[2] https://www.cancer.gov/about-cancer/treatment/drugport/drug/doxorubicin/patient
[3] https://patents.google.com/patent/US4753798A
[4] https://www.mayoclinic.org/drugs-supplements/doxorubicin-side-effects/drg-20069449
[5] https://www.apha.org/policies-and-advocacy/policy-statements/position-policy-statements/health-promotion-disease-prevent/medicine-access/